Our summary below outlines how Medicare Supplement carriers are underwriting – based on our Medicare Supplement Health Condition and Underwriting Filter.
*Male, 69 year old, non-tobacco, plan G In Tennessee
**For the previous full year, based upon CSG MarketEdge Tool.
| Alvesco (Emphysema) | bumetanide (Congestive Heart Failure) | Cognex (Alzheimers Disease) | Intron (Cancer) | Rapamune (Organ Transplant) |
|
|---|---|---|---|---|---|
| Carriers that Accept | 49.09% | 47.27% | 32.73% | 47.27% | 43.67% |
About CSG Actuarial
CSG Actuarial monitors insurance markets to provide the most up-to-date competitive intelligence in the industry. CSG’s MarketAdvisor™ Quoting Tools include premium rate and underwriting information for more than 300 companies.
To learn more, contact our sales team at 855-861-8776 or info@csgactuarial.com, or schedule your demo here.